Principal Financial Group’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-12,969
| Closed | -$233K | – | 2388 |
|
|
2020
Q2 | $233K | Buy |
12,969
+1,253
| +11% | +$17.4K | ﹤0.01% | 2146 |
|
|
2020
Q1 | $84K | Sell |
11,716
-9,350
| -44% | -$117K | ﹤0.01% | 2130 |
|
|
2019
Q4 | $503K | Buy |
21,066
+564
| +3% | +$15.6K | ﹤0.01% | 1946 |
|
|
2019
Q3 | $550K | Buy |
20,502
+1,946
| +10% | +$54.6K | ﹤0.01% | 1927 |
|
|
2019
Q2 | $504K | Sell |
18,556
-156
| -0.8% | -$4.89K | ﹤0.01% | 1959 |
|
|
2019
Q1 | $649K | Buy |
+18,712
| New | +$540K | ﹤0.01% | 1888 |
|
|
2018
Q4 | – | Sell |
-22,282
| Closed | -$593K | – | 2357 |
|
|
2018
Q3 | $593K | Buy |
22,282
+3,070
| +16% | +$100K | ﹤0.01% | 1933 |
|
|
2018
Q2 | $726K | Buy |
19,212
+1,054
| +6% | +$40.3K | ﹤0.01% | 1897 |
|
|
2018
Q1 | $593K | Sell |
18,158
-36,741
| -67% | -$1.61M | ﹤0.01% | 1916 |
|
|
2017
Q4 | $2.67M | Sell |
54,899
-7,230
| -12% | -$366K | ﹤0.01% | 1713 |
|
|
2017
Q3 | $3.36M | Sell |
62,129
-564
| -0.9% | -$33.1K | ﹤0.01% | 1661 |
|
|
2017
Q2 | $3.52M | Buy |
62,693
+371
| +0.6% | +$14.9K | ﹤0.01% | 1646 |
|
|
2017
Q1 | $2.44M | Buy |
62,322
+202
| +0.3% | +$6.43K | ﹤0.01% | 1702 |
|
|
2016
Q4 | $1.39M | Buy |
62,120
+9,657
| +18% | +$189K | ﹤0.01% | 1767 |
|
|
2016
Q3 | $1.19M | Buy |
52,463
+43,814
| +507% | +$1.03M | ﹤0.01% | 1746 |
|
|
2016
Q2 | $204K | Buy |
+8,649
| New | +$214K | ﹤0.01% | 2026 |
|
|
2016
Q1 | – | Sell |
-7,961
| Closed | -$410K | – | 2214 |
|
|
2015
Q4 | $410K | Hold |
7,961
| – | – | ﹤0.01% | 1883 |
|
|
2015
Q3 | $339K | Buy |
7,961
+1,011
| +15% | +$48.8K | ﹤0.01% | 1923 |
|
|
2015
Q2 | $317K | Buy |
6,950
+138
| +2% | +$5.55K | ﹤0.01% | 1941 |
|
|
2015
Q1 | $259K | Buy |
+6,812
| New | +$234K | ﹤0.01% | 1965 |
|
Principal Financial Group's PTLA Position: Q3 2020 in Review
Principal Financial Group sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 12,969 shares — an estimated $233K sold.
Principal Financial Group first reported a position in PTLA in Q1 2015 and held it in 20 quarters. The position peaked at $3.52M in Q2 2017. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.
- Principal Financial Group reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
- Principal Financial Group sold 12,969 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $233K.
- Principal Financial Group first reported a position in Portola Pharmaceuticals, Inc. in Q1 2015 and held it in 20 quarters.
- Principal Financial Group's Portola Pharmaceuticals, Inc. position peaked at $3.52M in Q2 2017.
- 0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.
Based on Principal Financial Group's 13F filing for Q3 2020, filed 6 Nov 2020.